|
|
 |
 |
|
* Reflects the two-for-one stock split effective March 2000.
(1) All historical financial information has been restated to reflect the acquisitions that were accounted for as poolings of interests (see Note 3 to the Consolidated Financial Statements).
(2) Net income and net income per common share include in-process research and development expenses of $461 million, payroll tax on stock option exercises of $26 million, amortization of goodwill and purchased intangible assets of $169 million, acquisition-related costs of $37 million, and net gains realized on minority investments of $344 million. Pro forma net income and diluted net income per common share, excluding these items net of tax of $53 million, were $1.20 billion and $0.16, respectively.
(3) Net income and net income per common share include in-process research and development expenses of $488 million, payroll tax on stock option exercises of $25 million, amortization of goodwill and purchased intangible assets of $51 million, and net gains realized on minority investments of $156 million. Pro forma net income and diluted net income per common share, excluding these items net of tax benefits of $44 million, were $1.01 billion and $0.13, respectively.
(4) Net income and net income per common share include in-process research and development expenses of $43 million, amortization of goodwill and purchased intangible assets of $47 million, acquisition-related costs of $25 million, and net gains realized on minority investments of $31 million. Pro forma net income and diluted net income per common share, excluding these items net of tax benefits of $3 million, were $897 million and $0.12, respectively.
(5) Net income and net income per common share include in-process research and development expenses of $381 million and amortization of goodwill and purchased intangible assets of $24 million. Pro forma net income and diluted net income per common share, excluding these items net of tax benefits of $6 million, were $814 million and $0.11, respectively.
(6) Net income and net income per common share include in-process research and development expenses of $81 million, amortization of goodwill and purchased intangible assets of $19 million, and acquisition-related costs of $16 million. Pro forma net income and diluted net income per common share, excluding these items net of tax benefits of $11 million, were $710 million and $0.10, respectively.
(7) Net income and net income per common share include amortization of goodwill and purchased intangible assets of $19 million. Pro forma net income and diluted net income per common share, excluding this item net of a tax benefit of $6 million, were $645 million and $0.09, respectively.
(8) Net income and net income per common share include in-process research and development expenses of $349 million and amortization of goodwill and purchased intangible assets of $12 million. Pro forma net income and diluted net income per common share, excluding these items net of tax benefits of $34 million, were $606 million and $0.09, respectively.
(9) Net income and net income per common share include in-process research and development expenses of $41 million and amortization of goodwill and purchased intangible assets of $11 million. Pro forma net income and diluted net income per common share, excluding these items net of tax benefits of $3 million, were $556 million and $0.08, respectively. |
|
|
|
|
|
|
